Krishna Yeshwant
CIK 1585001 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
24
Lifetime Open-Market Net
$3.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBLS | Director | — | — | — | $0 | 1 | 2026-06-11 |
| Verve Therapeutics, Inc. (VERV) Delisted | Director | 0 | $11.13 | $0 | $10.58M | 10 | 2025-07-28 |
| EQRx, Inc. (EQRXW) Delisted | Director | — | $0.05 | — | $0 | 2 | 2023-11-09 |
| Foundation Medicine, Inc. (FMI) Delisted | Director | 120,267 | — | — | -$7.25M | 10 | 2017-08-10 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-05-18 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −8,600 | -$331.7K | EDGAR |
| 2015-04-16 | Foundation Medicine, Inc. (FMI) Delisted | U | −952,192 | -$47.61M | EDGAR |
| 2015-04-09 | Foundation Medicine, Inc. (FMI) Delisted | U | −923,735 | -$46.19M | EDGAR |
| 2013-10-02 | Foundation Medicine, Inc. (FMI) Delisted | Conv (C) | +2,444,653 | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.